Skip to main content
Supplement ScienceSupplementScience

Phosphatidylcholine Side Effects & Safety

Evidence:Moderate
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Safety Profile

Overall safety rating: Generally Safe

Potential Side Effects

  • Mild GI symptoms (soft stools, bloating, nausea) at higher doses
  • Fishy body odor in rare cases due to trimethylamine production
  • Allergic reactions in people with soy allergy (use sunflower lecithin instead)
  • Very rare: diarrhea at high doses

Drug & Supplement Interactions

  • No significant drug interactions at standard doses
  • May enhance absorption of fat-soluble medications when taken together
  • Theoretically may increase the absorption of fat-soluble vitamins (A, D, E, K)
  • May complement the effects of other hepatoprotective supplements (synergistic with silymarin)

Maximum Dose

Do not exceed: 2400mg PPC/day (used in some clinical protocols)

Full Phosphatidylcholine Guide

References

  1. AnimalLieber CS, DeCarli LM, Mak KM, Kim CI, Leo MA (1990). Attenuation of alcohol-induced hepatic fibrosis by polyunsaturated lecithin. Hepatology. DOI PubMed
  2. RCTLieber CS, Weiss DG, Groszmann R, Paronetto F, Schenker S (2003). II. Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease. Alcoholism: Clinical and Experimental Research. DOI PubMed
  3. ReviewGundermann KJ, Kuenker A, Kuntz E, Droździk M (2016). Activity of essential phospholipids (EPL) from soybean in liver diseases. Pharmacological Reports. DOI PubMed
  4. Li J, Li Y, Wang J, Zhou Y, et al. (2025). Genetic evidence reveals phosphatidylcholine as a mediator in the causal relationship between omega-3 and multiple myeloma risk.. Scientific reports. DOI PubMed
  5. Meta-analysisStremmel W, Vural H, Evliyaoglu O, Weiskirchen R (2022). [Efficacy of enteric lecithin (phosphatidylcholine) in the treatment of ulcerative colitis: a meta-analysis].. MMW Fortschritte der Medizin. DOI PubMed
  6. Meta-analysisStremmel W, Vural H, Evliyaoglu O, Weiskirchen R (2021). Delayed-Release Phosphatidylcholine Is Effective for Treatment of Ulcerative Colitis: A Meta-Analysis.. Digestive diseases (Basel, Switzerland). DOI PubMed
  7. Mora-Ortiz M, Yubero-Serrano EM, Priego-Capote F, Gutierrez-Mariscal FM, et al. (2024). Dietary Lipid Quantity and Quality Modulate the Postprandial Metabolomic Profile in Patients with Metabolic Syndrome.. Nutrients. DOI PubMed
Show 3 more references
  1. Li CZ, Wu LM, Zhu CX, Du HY, et al. (2024). The impacts of dietary sphingomyelin supplementation on metabolic parameters of healthy adults: a systematic review and meta-analysis of randomized controlled trials.. Frontiers in nutrition. DOI PubMed
  2. Bantugan MA, Xian H, Solomon V, Lee M, et al. (2023). Associations of ApoE4 status and DHA supplementation on plasma and CSF lipid profiles and entorhinal cortex thickness.. Journal of lipid research. DOI PubMed
  3. Jin T, Kang G, Song S, Lee H, et al. (2023). The effects of dietary self-monitoring intervention on anthropometric and metabolic changes via a mobile application or paper-based diary: a randomized trial.. Nutrition research and practice. DOI PubMed